Cancer Research · 2014 · 35 citations · 44 references
MedicineCancer BiologyOncologyApoptosisMolecular OncologySignal TransductionApoptosis ResistanceCancer Cell SignalingGlioblastomaSignal Transduction In CancerApoptotic Signaling In CancerCancer Cell Survival SignalingGlioblastoma Molecular PathwaysGlioblastoma Targeted TherapyGlioblastoma Therapeutic ResistanceGlioblastoma Tumor BiologyTherapeutic Resistance MechanismsTherapeutic Target Identification
New therapeutic targets are needed that circumvent inherent therapeutic resistance of glioblastoma multiforme (GBM). Here, we report such a candidate target in the uncharacterized adaptor protein hMOB3, which we show is upregulated in GBM. In a search for its biochemical function, we found that hMOB3 specifically interacts with MST1 kinase in response to apoptotic stimuli and cell-cell contact. Moreover, hMOB3 negatively regulated apoptotic signaling by MST1 in GBM cells by inhibiting the MST1 cleavage-based activation process. Physical interaction between hMOB3 and MST1 was essential for this process. In vivo investigations established that hMOB3 sustains GBM cell growth at high cell density and promotes tumorigenesis. Our results suggest hMOB3 as a candidate therapeutic target for the treatment of malignant gliomas.
44
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
Jixin Dong, Georg Feldmann, Jianbin Huang et al. · Cell · 2007 · 2.4K citations · Full text
World Health Organization classification of tumors
Paul Kleihues, Leslie H. Sobin · Cancer · 2000 · 2.4K citations · Full text